World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
129
Citations
67596
World Ranking
2573
National Ranking
1445

Overview

Jeffrey E. Lee is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans the field of Medicine, with a substantial focus on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research, and Epidemiology.

The scientist's main topics of work include:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Cutaneous Melanoma Detection and Management
  • Neuroendocrine Tumor Research Advances
  • Pancreatitis Pathology and Treatment
  • Pain Management and Opioid Use
  • Cancer Immunotherapy and Biomarkers

Among recent publications involving Jeffrey E. Lee are:

  • "B cells and tertiary lymphoid structures promote immunotherapy response," 2020, Nature
  • "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response," 2021, Science
  • "Neoadjuvant relatlimab and nivolumab in resectable melanoma," 2022, Nature
  • "Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility," 2020, Nature Genetics
  • "Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma," 2020, JAMA Surgery

Frequent co-authors include:

  • Ching-Wei D. Tzeng
  • Matthew H. G. Katz
  • Naruhiko Ikoma
  • Michael P. Kim
  • Laura R. Prakash

Jeffrey E. Lee has published extensively in journals such as:

  • Annals of Surgical Oncology
  • Gastroenterology
  • Journal of Gastrointestinal Surgery
  • Journal of Surgical Oncology
  • Annals of Surgery

Best Publications

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

    Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee

  • Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

    Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong

  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

    Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun

  • Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

    Jeffrey E. Lee;Marnie L. Fusco;Ann J. Hessell;Wendelien B. Oswald

  • Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

    Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun

  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Rodabe N. Amaria;Sangeetha M. Reddy;Hussein A. Tawbi;Michael A. Davies

  • Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals

    Marcia Irene Canto;Ralph H. Hruban;Elliot K. Fishman;Ihab R. Kamel

  • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer

    Maria A Kouvaraki;Suzanne E Shapiro;Bruno D Fornage;Beth S Edeiken-Monro

  • Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

    Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang

  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

    Jennifer L. McQuade;Carrie R. Daniel;Kenneth R. Hess;Carmen Mak

  • MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

    David H.F. Teng;Rong Hu;Huai Lin;Thaylon Davis

  • Pancreaticoduodenectomy with vascular resection: margin status and survival duration

    Jennifer F. Tseng;Chandrajit P. Raut;Jeffrey E. Lee;Peter W.T. Pisters

  • Detectable clonal mosaicism from birth to old age and its relationship to cancer.

    Cathy C. Laurie;Cecelia A Laurie;Kenneth Rice;Kimberly F. Doheny

  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    F. R. Spitz;J. L. Abbruzzese;Jeffrey E Lee;Peter W Pisters

  • Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

    Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

    Matthew Harold Katz;Jason B Fleming;Priya R Bhosale;Gauri R Varadhachary

  • Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

    Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun

Frequent Co-Authors

Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
Jason B. Fleming
Jason B. Fleming The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jean Nicolas Vauthey
Jean Nicolas Vauthey The University of Texas MD Anderson Cancer Center
Merrick I. Ross
Merrick I. Ross The University of Texas MD Anderson Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
Qingyi Wei
Qingyi Wei Duke University
Janice N. Cormier
Janice N. Cormier The University of Texas MD Anderson Cancer Center
Christopher I. Amos
Christopher I. Amos Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your medical career options beyond traditional MD programs? The USA offers a wide variety of online degrees in the healthcare field, allowing students and professionals greater flexibility and a wider range of career pathways. Programs like bsn to np programs online provide a fast track for registered nurses who wish to advance to nurse practitioner roles, especially in high-demand areas like psychiatric and mental health care.

For those drawn to the business side of healthcare, a health administration degree online opens doors to leadership and administrative positions in hospitals and healthcare systems. If cost is a concern, exploring the cheapest mha online programs can help you find quality education at an affordable price.

Nurses seeking the highest levels of clinical practice can opt for msn to dnp programs online, which prepare advanced practice nurses for leadership, teaching, or specialized clinical roles. Each of these online pathways makes it easier to balance work, study, and personal commitments while advancing your healthcare career.

Best Scientists Citing Jeffrey E. Lee

Trending Scientists

Recently Published Articles